NEW YORK (GenomeWeb) – Life science omics tools and molecular diagnostics stocks eked out a small gain in July lifted by the relative strength of the broader biotechnology space. 

The GenomeWeb Index rose a fraction of 1 percent compared to June, as 17 companies saw gains in their share prices while 15 firms saw declines in their stocks. The index beat the Dow Jones Industrial Average, which improved a fraction of 1 percent, but it trailed the Nasdaq, which was up about 3 percent, and the Nasdaq Biotech Index, which grew almost 4 percent. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.